Study of a Patient Cohort Following Digestive Surgical Care After the Implementation of a Telemonitoring and Tele-coordination Platform for Medical, Paramedical, and Social Management
NCT07186738 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2025-09-22
Summary
Postoperative hospital stays and complications vary widely after digestive surgery. Enhanced Recovery After Surgery (ERAS) protocols have shortened stays and accelerated recovery after elective procedures, but they remain challenging in emergency surgery and among frail or elderly patients. While theoretical discharge after colorectal surgery is possible between postoperative days 2 and 7, average stays in practice are 12-14 days. Bariatric surgery similarly targets discharge on days 2-3, yet typical stays are 8-10 days. Patients successfully managed under ERAS may face higher readmission risk, often due to worsening comorbidities or serious complications.
Prolonged hospitalization and readmissions impact patient safety, comfort, and healthcare costs. Daily hospital costs in surgical units range from €350 to €400. Post-acute care facilities can reduce readmissions but often have long waiting periods. To minimize readmission risk, many surgeons prefer in-hospital postoperative monitoring, limiting early discharge.
Recent studies show that connected devices and teleconsultation can provide safe and effective postoperative follow-up. Teleconsultation follow-up is feasible for most patients, with satisfaction rates comparable to in-person visits. Remote monitoring of stoma care has been associated with reduced readmissions. Home-based monitoring using connected vital sign devices in high-risk patients reduces readmissions and emergency visits. In colorectal and bariatric surgery, daily remote monitoring after early discharge (24-48 hours) did not increase morbidity or readmission, suggesting that telemonitoring can safely enable earlier discharge while maintaining patient safety. Continuous monitoring is particularly important for high-risk patients due to rapid deterioration from potential complications.
EPOCA is a telemonitoring and telecoordination platform providing medical, paramedical, and social follow-up at home. It combines connected devices, a digital platform for data analysis, and a dedicated medical and paramedical team. Services include teleconsultations, home paramedical care, support for families or care facilities, and 24/7 emergency management.
EPOCA reassures patients and caregivers, supports primary care and home care teams, and integrates hospital and emergency services. It addresses challenges posed by aging populations, chronic disease prevalence, and increasingly complex patients. By enabling earlier discharge without increasing readmissions, EPOCA offers a holistic solution bridging hospital and home care. It has already demonstrated success in preventing hospitalizations in high-risk elderly patients and is authorized for telemonitoring of chronic conditions including diabetes, respiratory, renal, and cardiac insufficiency.
This study aims to evaluate the feasibility of implementing EPOCA over two years in the CHU Nantes digestive surgery unit. It will target patients undergoing elective or urgent colorectal or bariatric surgery who are at risk of prolonged hospitalization or readmission. High-risk scenarios include anticipated early discharge within 24 hours and patients identified as having elevated readmission risk according to predefined criteria
Conditions
- Telemonitoring
Interventions
- DEVICE
-
EPOCA telemonitoring
EPOCA is a telemonitoring and tele-coordination platform for medical, paramedical, and social care, enabling the follow-up of acute or chronic patients at home-whether after hospital discharge, as an alternative to hospitalization, or for long-term monitoring. The EPOCA solution relies on connected devices, a digital platform for analyzing incoming data, and a team of medical and paramedical professionals for monitoring and coordination. Remote medical monitoring includes teleconsultations, at-home paramedical care, guidance and support for families, nursing homes, or long-term care facilities, and 24/7 management of home emergencies
Sponsors & Collaborators
-
Nantes University Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-10-01
- Primary Completion
- 2026-02-01
- Completion
- 2027-10-01
Countries
- France
Study Locations
More Related Trials
-
Enhanced Recovery After Surgery Protocol on Early Mobilization After Colorectal Surgery
NCT06065696 ·Status: COMPLETED
-
Compliance With Enhanced Recovery After Surgery Protocol (ERAS) in Surgical Patients
NCT03968666 ·Status: UNKNOWN
-
Enhanced Recovery After Surgery (ERAS) in Gynecological Surgery (ERASGS-01)
NCT03629626 ·Status: COMPLETED ·Phase: NA
-
Postoperative Nausea and Vomiting: to Estimate the Incidence and Risk Factors in a Tertiary Teaching Hospital
NCT02689128 ·Status: UNKNOWN
-
Comparison of the Effects of Continuous Epidural Analgesia and Continuous Intravenous Analgesia on Postoperative Bowel Movement in Patients Undergoing Laparoscopic Gastrectomy
NCT02458573 ·Status: COMPLETED ·Phase: PHASE4
-
Dexamethasone and Ondansetron Versus Placebo for Postoperative Nausea and Vomiting
NCT01876290 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of taVNS Combined With Dexmedetomidine on POVN
NCT07271147 ·Status: RECRUITING ·Phase: NA
-
Conventional VS Enhanced Recovery After Surgery Protocols in Emergency GIT Surgery
NCT04584060 ·Status: UNKNOWN
-
The Effect of Combining Aprepitant With Ondansetron in High-risk Patients for Postoperative Nausea and Vomiting
NCT01897337 ·Status: COMPLETED ·Phase: PHASE4
-
Continuous Infusion of Palonosetron for Preventing of Postoperative Nausea and Vomiting
NCT01482468 ·Status: UNKNOWN ·Phase: NA
-
Effects of Insufflated Gas on Core Temperature and Post-operative Pain During Laparoscopic Surgery
NCT00372268 ·Status: COMPLETED ·Phase: NA
-
Early Diuresis Following Colorectal Surgery
NCT02351934 ·Status: COMPLETED ·Phase: PHASE4
-
Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis
NCT02625181 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Low Dose Promethazine for Postoperative Nausea and Vomiting
NCT01159548 ·Status: TERMINATED ·Phase: NA
-
Evaluation of the Benefit of Non-opioid General Anaesthesia on Postoperative Pain in Laparoscopic Colonic Surgery
NCT05031234 ·Status: COMPLETED ·Phase: NA
-
Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy
NCT03435003 ·Status: COMPLETED ·Phase: PHASE4
-
PONV Prevention Via Percutaneous Nerve Electrical Stimulation on PC6
NCT06241547 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Laryngeal Mask in Upper Gastrointestinal Procedures
NCT03567928 ·Status: TERMINATED ·Phase: NA
-
Ropivacaine-Poloxamer 407 Gel for Pain Control After Open Gastrectomy
NCT06778954 ·Status: RECRUITING ·Phase: NA
-
Immediate Post-operative Recovery After Regional vs. General Anesthesia
NCT03047148 ·Status: COMPLETED
-
Dual-chamber Patient-controlled Analgesia for Postoperative Recovery
NCT07051109 ·Status: RECRUITING ·Phase: NA
-
Postoperative Gastric Point of Care Ultrasound (G-POCUS) in Abdominal Surgery
NCT05796063 ·Status: UNKNOWN ·Phase: NA
-
Postoperative Outcomes After Positive Intraoperative Messages
NCT02765750 ·Status: TERMINATED ·Phase: NA
-
Post-Operative Nausea And Vomiting Study In Female Patients
NCT00274690 ·Status: COMPLETED ·Phase: PHASE2
-
Aprepitant for PONV Prophylaxis in Outpatient Plastic Surgery
NCT00659945 ·Status: COMPLETED ·Phase: PHASE4